JULIE HANNAH: Open Payments
NPI 1770890592 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 30 payments from 14 companies in 2025. Trend: 2023 $465 · 2024 $481 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $115 |
| Merck Sharp & Dohme LLC | 7 | $109 |
| Novo Nordisk Inc | 4 | $76 |
| Actelion Pharmaceuticals US, Inc. | 3 | $53 |
| ABIOMED | 2 | $49 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| United Therapeutics Corporation | 1 | $20 |
Products named: ULTOMIRIS, VERQUVO, Wegovy, UPTRAVI, LifeVest, JARDIANCE, Adempas, GLASSIA.
Industry payments across IN — which companies pay providers there.
